SENS home

SENS 2 home

Sponsors

Proceedings

Local information

Travel information

Abstract submission

Accepted abstracts

Registration

First SENS
conference

Meeting Program

Wednesday 7th September
11:00-13:15: Registration
13:15Aubrey de Grey
University of Cambridge
Welcome and introductory remarks
Session 1: Tissue regeneration and engineering (Chair: Bob Lightowlers)
13:20 Tony Atala
Wake Forest University
Tissue engineering, stem cells and cloning: current concepts and changing trends
13:50 Buddy Ratner
University of Washington
To engineer a heart
14:20 Ellen Heber-Katz
Wistar Institute
Can continuous regeneration lead to immortality? Studies in the MRL mouse
14:50 Gregory Fahy
21st Century Medicine
Cryopreservation of complex living systems: the missing link in the regenerative medicine supply chain
15:20Coffee
Session 2: Frontiers of somatic gene and enzyme therapy (Chair: Buddy Ratner)
15:40 Matthew Porteus
University of Texas
Using zinc finger nucleases to manipulate the mammalian genome
16:10 Weihong Pan
Pennington Biomedical Research Center
Delivery of enzymes and neurotrophic proteins to treat CNS disorders
16:40 James Larrick
Transomix, Inc.
Revolutionizing transgenesis and gene disruptions using P-element transposition
17:10 Fulvio Mavilio
U. Modena and MolMed S.p.A.
Genetic modification of hematopoietic stem cells: from bench to bedside....and back
17:40Coffee
Session 3: Overcoming mitochondrial mutations (Chair: Fulvio Mavilio)
18:00 Bob Lightowlers
University of Newcastle
Nucleic acid delivery to mitochondria - myth or reality?
18:30 Takao Yagi
Scripps Institute
Can a single subunit NADH dehydrogenase rescue complex I defects?
19:00 Rafal Smigrodzki
Gencia Corporation
Microheteroplasmy and protofection - the why and how of mtDNA replacement therapy
19:30 Henry Weiner
Purdue University
Factors that might affect the allotopic replacement of a damaged mitochondrial DNA-encoded protein
20:00 Dinner
21:00 Welcome reception and Poster session 1
Thursday 8th September
7:30 Breakfast
Session 4: Stem cell therapies in the clinic (Chair: Judd Aiken)
8:30 Amit Patel
University of Pittsburgh
Does stem cell therapy for ischemic cardiomyopathy result in the improvement of congestive heart failure?
9:00 James Conner
University of California San Diego
Ex vivo gene delivery of NGF in Alzheimer's Disease
9:30 Paul Sharpe
King's College London
Tissue engineering teeth
10:00 Chang-Hun Song
Chosun University
Clinical application of human umbilical cord blood mesenchymal stem cells
10:30 Coffee
Session 5: Overcoming sarcopenia, adiposity and their sequelae (Chair: Matthias Stelzner)
10:50Judd Aiken
University of Wisconsin-Madison
The role of mtDNA deletion mutations in sarcopenia
11:20Irina Conboy
University of California Berkeley
Understanding and reversing aging of muscle precursor cells
11:50Roger Unger
University of Texas
Leptin and longevity: blocking the consequences of lipid overload
12:20Ronald Kahn
Joslin Institute
Role of insulin action and gene expression in adipose tissue in aging
12:50 Lunch
Session 6: short talks: immunosenescence, growth factors, other (Chairs: Alexander Bürkle, Russ Hepple)
13:50 Alexander Bürkle
University of Konstanz
Poly(ADP-ribosyl)ation capacity of human T lymphocytes in vitro and in vivo as a function of age
14:05 Calogero Caruso
University of Palermo
Biology of longevity: role of the immune system
14:20 Stanley Primmer
Los Angeles Gerontology Research Group
The Supercentenarian Research Foundation
14:35 Andrew Dillin
Salk Institute
SMK-1, an essential regulator of DAF-16/FOXO3a mediated longevity
14:50 Russell Hepple
University of Calgary
Caloric restriction protects mitochondrial function with aging in skeletal and cardiac muscles
15:05 Eugenio Mocchegiani
Istituto Nazionale Riposo e Cura Anziani
Zinc homeostasis in aging: two elusive faces of the same metal
15:20 D. James Morré
Purdue University
Aging-related cell surface ECTO-NOX protein, arNOX, a preventive target to reduce atherogenic risk in the elderly
15:35 Chris Heward
Kronos Science Laboratory
Negligible senescence - how will we know it when we see it?
15:50Coffee
Session 7: SCNT and stem cells (1) (Chair: Paul Schiller)
16:10 Woo Suk Hwang
Seoul National University
Patient-specific embryonic stem cells derived from human SCNT-blastocysts
16:40 José Cibelli
Michigan State University
Parthenogenetic embryonic stem cells in primates
17:10 Gerald Schatten
University of Pittsburgh
Aging research enabled by patient-specific embryonic stem cells derived from human SCNT-blastocysts
17:40 Coffee
Session 8: SCNT and stem cells (2) (Chair: Jerry Schatten)
18:00 Geoff Margison
Paterson Institute
Protection and selection for gene therapy in the haemopoietic system
18:30 Teresa Holm (Jaenisch lab)
Massachusetts Institute of Technology
Global loss of imprinting in embryonic stem cells leads to widespread tumorigenesis in adult mice
19:00 Paul Schiller
University of Miami
Sustained stromal stem cell self-renewal and osteoblastic differentiation during aging
19:30 Matthias Stelzner
Greater Los Angeles Health Care System
To make a new intestinal mucosa
20:00 Dinner
21:00 Poster session 2
Friday 9th September
7:30 Breakfast
Session 9: Ellison Medical Foundation Session: Removal of intracellular aggregates (1) (Chair: Ana Maria Cuervo)
8:30 Bruce Rittmann
Arizona State University
The microbiological foundation for bioremediating intracellular aggregates
9:00 Janet Sparrow
Columbia University
The lipofuscin of the retinal pigment epithelium
9:30 Jay Jerome
Vanderbilt University
Abnormal lysosomal processing of internalized cholesteryl esters in macrophages
10:00 Wendy Jessup
University of New South Wales
Oxidized lipids in atherosclerotic macrophages: what role do they play in foam cell formation?
10:30 Coffee
Session 10: Ellison Medical Foundation Session: Removal of intracellular aggregates (2) (Chair: Jay Jerome)
10:50 David Rubinsztein
University of Cambridge
Macroautophagy upregulation - a candidate therapeutic strategy to enhance clearance of toxic intracellular aggregate-prone proteins
11:20 Ralph Nixon
Nathan Kline Institute
Autophagy in Alzheimer's Disease Pathogenesis
11:50 Ana Maria Cuervo
Albert Einstein College of Medicine
Reactivating chaperone-mediated autophagy: the advantages of preserving a selective autophagy
12:20 Roscoe Brady
National Institutes of Health
Current and future stategies for the treatment of metabolic storage disorders
12:50 Lunch
SENS Lecture (Chair: Aubrey de Grey)
13:50 Michael West
Advanced Cell Technology
Strategies for the reversal of the aging of human somatic cells
Session 11: short talks: aggregate- and crosslinking-related aspects of aging (Chair: Aubrey de Grey)
14:35 Elizabeth Corder
Duke University
Membership in high-risk genetic groups predicts Alzheimer's disease and age-at-onset
14:50 Stuart Wilson
PAD Pharma
Tackling the diseases of old age; progress towards an Alzheimer's therapeutic
15:05 Ruth Itzhaki
University of Manchester
Herpes simplex virus type 1 in brain and apolipoprotein E type 4 allele: a dangerous liaison for Alzheimer's disease
15:20 John Furber
Legendary Pharmaceuticals
Glucosepane crosslink breakers: necessity and prospects
15:35 Shalesh Kaushal
University of Florida
Manipulating the intracellular fate of an aggregate-prone protein
15:50Coffee
Session 12: Immune modulation (rejuvenation and tolerisation) (1) (Chair: Graham Pawelec)
16:10 Susan Swain
Trudeau Institute
The Impact of Aging on CD4 T Cell Function
16:40 Deborah Dunn-Walters
King's College London
Antibody quality in old age
17:10 Matthias Reddehase
University of Mainz
Immune sensing of latent cytomegalovirus reactivation and its possible impact on immune senescence
17:40 Coffee
Session 13: Immune modulation (rejuvenation and tolerisation) (2) (Chair: Deborah Dunn-Walters)
18:00Michael Sela
Weizmann Institute
Immunomodulatory vaccines against autoimmune diseases
18:30Megan Sykes
Harvard University
Immune tolerance induction: From bench to bedside
19:00Marilyn Thoman
Sidney Kimmel Cancer Center
Thymic rejuvenation by engineered cells secreting IL-7 in situ
19:30Graham Pawelec
University of Tübingen
Immunorejuvenation in the elderly
20:00 Dinner
21:00 Poster session 3
Saturday 10th September
7:30 Breakfast
Session 14: 21st-century anti-cancer therapies (1) (Chair: Dorothy Morré)
8:30 Bob Marciniak
University of Texas
A novel form of ALT telomere maintenance in human cells
9:00 Edwin Goodwin
Los Alamos National Laboratory
Telomere dynamics and cell proliferation
9:30 Maria Blasco
Spanish National Cancer Centre
Telomeres and human disease: a matter of bad ends
10:00Aubrey de Grey
University of Cambridge
WILT: still crazy after both these years?
10:30 Coffee
Session 15: 21st-century anti-cancer therapies (2) (Chair: Ed Goodwin)
10:50Judith Campisi
Lawrence Berkeley National Laboratory
Cellular senescence, cancer and aging
11:20Manuel Serrano
Spanish National Cancer Center
Mice with improved systems for cellular quality control: super-p53 and super-p16/ARF mice
11:50Daniel Meruelo
New York University
Gene therapy that safely targets and kills tumor cells throughout the body
12:20Dorothy Morré
Purdue University
Catechin-vanilloid synergies with potential clinical applications in cancer
12:50 Lunch
Session 16: short talks: cell number control (stem cells, SCNT, proliferation, senescence, apoptosis, cancer) (Chairs: Gabi Saretzki, Diana van Heemst)
13:50 Alexandra Stolzing
University of Sheffield
Senescence in mesenchymal stem cells: the effects of reduced culture temperature and media glucose concentration
14:05 John Allen
Queen Mary, University of London
Sex as a division of labour between mitochondria
14:20 Andrei Rybouchkin
Kinki University
Enhanced reprogramming to facilitate production of somatic cell NT ES cell lines
14:35 Gabriele Saretzki
Newcastle University
Telomerase decreases ROS levels but does not counteract telomere shortening under oxidative stress
14:50 Yousin Suh
University of Texas
Apoptosis, genome maintenance, and aging
15:05 Diana van Heemst
Leiden University Medical Center
Cellular ageing in fibroblast cultures from elderly aged 90 years old
15:20 Werner Zwerschke
Austrian Academy of Sciences
Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis
15:35 Karl Riabowol
University of Calgary
Chromatin remodeling may enforce cell senescence
15:50Coffee
Session 17: Repair/removal of pathogenic extracellular material (1) (Chair: Matthew Collins)
16:10 Dean Jones
Emory University
Extracellular redox state: refining the definition of oxidative stress in aging
16:40 Vincent Monnier
Case Western Reserve University
Enzymic repair and prevention of chemical aging by the Maillard reaction in vivo
17:10 Howard Haimes
Alteon Pharmaceuticals
Alagebrium: Intervention on the A.G.E. pathway modifies deficits caused by aging and diabetes
17:40 Coffee
Session 18: Repair/removal of pathogenic extracellular material (2) (Chair: Vincent Monnier)
18:00 Matthew Collins
University of York
The decay of extra-cellular matrix proteins; an inevitable consequence of old age?
18:30 Vernon Ingram
Massachusetts Institute of Technology
Alzheimer's, Huntington's and Prion Diseases - why are misfolded proteins so interesting, but so destructive?
19:00 Cynthia Lemere
Harvard University
A-beta immunotherapy: lessons from mice, monkeys, and men
19:30 Mark Pepys
Royal Free & University College Medical School
Ageing, amyloid and amyloidosis: from pathogenesis to therapy
20:00Gala Dinner
Sunday 11th September
7:30 Breakfast
9:30 Punting on the Cam
11:30 C O N F E R E N C E   A D J O U R N S
Thank you for your attendance and participation!



Problems or questions regarding this site should be directed to the organiser.